Your browser doesn't support javascript.
loading
A multicenter investigator-initiated Phase 2 trial of E7090 in patients with advanced or recurrent solid tumor with fibroblast growth factor receptor (FGFR) gene alteration: FORTUNE trial.
Chiba, Yohei; Sudo, Kazuki; Kojima, Yuki; Okuma, Hitomi; Kohsaka, Shinji; Machida, Ryunosuke; Ichimura, Masahiko; Anjo, Kenta; Kurishita, Kazumi; Okita, Natsuko; Nakamura, Kenichi; Kinoshita, Ichiro; Takahashi, Masanobu; Matsubara, Junichi; Kusaba, Hitoshi; Yonemori, Kan; Takahashi, Masamichi.
Afiliação
  • Chiba Y; Department of Medical Oncology, National Cancer Center Hospital, Tokyo, Japan.
  • Sudo K; Department of Medical Oncology, National Cancer Center Hospital, Tokyo, Japan.
  • Kojima Y; Department of Experimental Therapeutics, National Cancer Center Hospital, Tokyo, Japan.
  • Okuma H; Department of International Clinical Development, National Cancer Center Hospital, Tokyo, Japan.
  • Kohsaka S; Department of Medical Oncology, National Cancer Center Hospital, Tokyo, Japan.
  • Machida R; Department of International Clinical Development, National Cancer Center Hospital, Tokyo, Japan.
  • Ichimura M; Department of Medical Oncology, National Cancer Center Hospital, Tokyo, Japan.
  • Anjo K; Department of International Clinical Development, National Cancer Center Hospital, Tokyo, Japan.
  • Kurishita K; Clinical Research Support Office, National Cancer Center Hospital, Tokyo, Japan.
  • Okita N; Division of Cellular Signaling, National Cancer Center Research Institute, Tokyo, Japan.
  • Nakamura K; Clinical Research Support Office, National Cancer Center Hospital, Tokyo, Japan.
  • Kinoshita I; Clinical Research Support Office, National Cancer Center Hospital, Tokyo, Japan.
  • Takahashi M; Clinical Research Support Office, National Cancer Center Hospital, Tokyo, Japan.
  • Matsubara J; Clinical Research Support Office, National Cancer Center Hospital, Tokyo, Japan.
  • Kusaba H; Clinical Research Support Office, National Cancer Center Hospital, Tokyo, Japan.
  • Yonemori K; Clinical Research Support Office, National Cancer Center Hospital, Tokyo, Japan.
  • Takahashi M; Division of Clinical Cancer Genomics, Hokkaido University Hospital, Hokkaido, Japan.
BMC Cancer ; 22(1): 869, 2022 Aug 09.
Article em En | MEDLINE | ID: mdl-35945547
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Receptores de Fatores de Crescimento de Fibroblastos / Neoplasias Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Receptores de Fatores de Crescimento de Fibroblastos / Neoplasias Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article